JLL-backed EVERSANA acquires London HEOR firm Estima Scientific

EVERSANA, a provider of commercial services to the biopharmaceutical industry, announced the acquisition of Estima Scientific, a London-based health economics and outcomes research (HEOR) technology and services company. Estima has joined EVERSANA, and its co-founders Tim Reason and Andy Gimblett will join EVERSANA's global workforce.

Estima will integrate its consulting expertise and proprietary generative-AI software into EVERSANA's market access and value and evidence solutions. The company said the deal supports its AI-enabled, technology-first strategy, and EVERSANA CEO Mark Thierer said the Estima team would fit into the organization. The financial terms were not disclosed. Bourne Partners advised Estima Scientific as exclusive financial adviser, and Wedlake Bell acted as legal adviser.